M. Ramirez-Gama

Dupilumab significantly improves skin barrier function in patients with moderate‐to‐severe atopic dermatitis

A. Praestgaard, M. Boguniewicz, A. Zhang, 2022, Allergy.

Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial

R. Gallo, D. Leung, B. Jepson, 2021, Nature Medicine.

The nonlesional skin surface distinguishes atopic dermatitis with food allergy as a unique endotype

R. Cole, K. Zengler, P. Elias, 2019, Science Translational Medicine.

Unique skin abnormality in patients with peanut allergy but no atopic dermatitis.

P. Elias, D. Leung, E. Goleva, 2020, The Journal of allergy and clinical immunology.

Dupilumab inhibits vascular leakage of blood proteins into atopic dermatitis skin.

M. Boguniewicz, A. Zhang, R. Bissonnette, 2023, Journal of Allergy and Clinical Immunology: In Practice.